Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Sarcoma × fludarabine phosphate × Clear all

Phase

Status

Recruiting 2 Completed 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 17 Myelodysplastic Syndromes 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Non-Hodgkin 10 Lymphoma 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia 7 Recurrence 6 Multiple Myeloma 6 Hodgkin Disease 6 Neoplasms 5 Myeloproliferative Disorders 5 Melanoma 5 Lymphoma, B-Cell 5 Leukemia, Biphenotypic, Acute 5 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Leukemia, Myelomonocytic, Juvenile 4 Immunoproliferative Disorders 4 Immune System Diseases 4 Precancerous Conditions 3 Neoplasm, Residual 3 Lymphoproliferative Disorders 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphatic Diseases 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphoid 3 Hematologic Neoplasms 3

Interventions

Nivolumab 10 pembrolizumab 9 Radiotherapy 9 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Doxorubicin 8 Cyclophosphamide 7 Biopsy 7 X-Rays 6 Ipilimumab 6 Phantoms, Imaging 5 talimogene laherparepvec 4 Radiation 4 Nuclear Medicine Department, Hospital 4 selpercatinib 3 pazopanib 3 palbociclib 3 cabozantinib 3 Standard of Care 3 Sirolimus 3 Ifosfamide 3 Bevacizumab 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 olaparib 2 liposomal doxorubicin 2 larotrectinib 2 ivosidenib 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00902044 2026-01-26

HEROS

Baylor College of Medicine

Phase 1 Active not recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡